Understanding ALK+ NSCLC? Dive into this illuminating session as Dr. Millie Das, a renowned oncologist, breaks down what ‘ALK+’ signifies in the context of lung cancer. This special segment is part of the 2022 Targeted Therapies Forum, connecting you with the latest insights in oncology.
Our deepest appreciation to our dedicated sponsors: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech. Your support continually pushes the boundaries of cancer research and patient care.
Stay abreast of the evolving world of cancer treatments. Learn more and enrich your knowledge at http://cancerGRACE.org/. Engage, ask, and converse with our global community at https://cancergrace.org/forum.